HEPA - PRICE - Hepion Pharmaceuticals

The Hepion Pharmaceuticals (HEPA) market price chart on the GURU.Markets platform demonstrates the dynamics of the asset, which is valued at . Hepion Pharmaceuticals develops global liver medications with minimal production costs, ensuring high margins. The business focuses on the therapy of chronic pathologies, securing multi-year customer loyalty through patent protection. Meanwhile, the development of new formulas is conducted in in-house centers, while series production is delegated to reliable contractors.

Investors are assessing the potential of Hepion Pharmaceuticals (HEPA) by comparing the stock's market value with its intrinsic value, where the price serves as the current cash equivalent of a single equity stake in the business. Analyzing this price chart reveals how quotes react to the efficiency of budget management for liver drug clinical trials and the team's success in securing strategic partners.